Clinical Presentation and Management of SMART Syndrome

Affiliations

• ¹ From the Massachusetts General Hospital Cancer Center (S.F.W., E.J.V., P.K., J.D.) and Center for Neuro-Oncology, Dana-Farber Cancer Institute (E.Q.L.), Harvard Medical School; Division of Neuro-Oncology, Department of Neurology (S.F.W., E.J.V., P.K., J.D.), and Department of Radiation Oncology (H.A.S.), Massachusetts General Hospital and Harvard Medical School, Boston; Department of Neurosurgery (S.F.W., F.L.), Charité Universitatsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Germany; Departments of Neurology and Radiology (J.P.K.), Brigham and Women's Hospital and Harvard Medical School, Boston, MA; Department of Radiation Oncology (E.J.V.), Duke Cancer Institute, Durham, NC; and Department of Neurosurgery (P.K.), Ludwig Maximilians University, Munich, Germany.
• ² From the Massachusetts General Hospital Cancer Center (S.F.W., E.J.V., P.K., J.D.) and Center for Neuro-Oncology, Dana-Farber Cancer Institute (E.Q.L.), Harvard Medical School; Division of Neuro-Oncology, Department of Neurology (S.F.W., E.J.V., P.K., J.D.), and Department of Radiation Oncology (H.A.S.), Massachusetts General Hospital and Harvard Medical School, Boston; Department of Neurosurgery (S.F.W., F.L.), Charité Universitatsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Germany; Departments of Neurology and Radiology (J.P.K.), Brigham and Women's Hospital and Harvard Medical School, Boston, MA; Department of Radiation Oncology (E.J.V.), Duke Cancer Institute, Durham, NC; and Department of Neurosurgery (P.K.), Ludwig Maximilians University, Munich, Germany. dietrich.jorg@mgh.harvard.edu.